These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28502722)

  • 1. Radiotherapy Rescue of a Nivolumab-Refractory Immune Response in a Patient with PD-L1-Negative Metastatic Squamous Cell Carcinoma of the Lung.
    Yuan Z; Fromm A; Ahmed KA; Grass GD; Yang GQ; Oliver DE; Dilling TJ; Antonia SJ; Perez BA
    J Thorac Oncol; 2017 Sep; 12(9):e135-e136. PubMed ID: 28502722
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report.
    Li H; Ma W; Yoneda KY; Moore EH; Zhang Y; Pu LL; Frampton GM; Molmen M; Stephens PJ; Li T
    J Hematol Oncol; 2017 Feb; 10(1):64. PubMed ID: 28245875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab.
    Khunger M; Velcheti V
    J Thorac Oncol; 2017 Jul; 12(7):e96-e97. PubMed ID: 28629548
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Treated with Nivolumab.
    Funazo T; Nomizo T; Kim YH
    J Thorac Oncol; 2017 Sep; 12(9):e140-e141. PubMed ID: 28838713
    [No Abstract]   [Full Text] [Related]  

  • 5. Intracranial Response to Nivolumab in a Patient with PD-L1-negative Lung Adenocarcinoma.
    Nakahara Y; Fukui T; Shirasawa M; Harada S; Kusuhara S; Takakura A; Yokoba M; Mitsufuji H; Kubota M; Katagiri M; Sasaki J; Masuda N; Inukai M; Sekiguchi T; Naoki K
    Intern Med; 2018 Nov; 57(21):3149-3152. PubMed ID: 29877291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nivolumab in the treatment of metastatic squamous non-small cell lung cancer: a review of the evidence.
    Lim JS; Soo RA
    Ther Adv Respir Dis; 2016 Oct; 10(5):444-54. PubMed ID: 27480166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program.
    Garassino MC; Crinò L; Catino A; Ardizzoni A; Cortesi E; Cappuzzo F; Bordi P; Calabrò L; Barbieri F; Santo A; Altavilla G; Ambrosio F; Mini E; Vasile E; Morgillo F; Scoppola A; Bengala C; Follador A; Tedde N; Giannarelli D; Lo Russo G; Vitiello F
    Tumour Biol; 2018 Nov; 40(11):1010428318815047. PubMed ID: 30486741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Skin Reaction Induced by Nivolumab Combined with Radiotherapy in Non-small Cell Lung Cancer: A Case Report.
    Zhao ZM; Liu SC; Xu XJ; Zhang ZF; Nie KK; Ji YX
    Chin Med Sci J; 2018 Sep; 33(3):183-187. PubMed ID: 30266109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy.
    Kazandjian D; Suzman DL; Blumenthal G; Mushti S; He K; Libeg M; Keegan P; Pazdur R
    Oncologist; 2016 May; 21(5):634-42. PubMed ID: 26984449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer.
    Komatsu T; Nakamura K; Kawase A
    J Thorac Oncol; 2017 Sep; 12(9):e143-e144. PubMed ID: 28838715
    [No Abstract]   [Full Text] [Related]  

  • 11. Atypical response with bone pseudoprogression in a patient receiving nivolumab for advanced cutaneous squamous cell carcinoma.
    Oliveira LJC; Gongora ABL; Barbosa FG; Dos Anjos CH; Munhoz RR
    J Immunother Cancer; 2018 Nov; 6(1):130. PubMed ID: 30482243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does nivolumab for progressed metastatic lung cancer fulfill its promises? An efficacy and safety analysis in 20 general hospitals.
    Tournoy KG; Thomeer M; Germonpré P; Derijcke S; De Pauw R; Galdermans D; Govaert K; Govaerts E; Schildermans R; Declercq I; De Brucker N; Pat K; Van Herreweghe R; Van Zandweghe L; Vanmaele L; Van Damme V; Marien H; De Craene S; Fabry I; Alexander P; Vercauter P; Demedts I
    Lung Cancer; 2018 Jan; 115():49-55. PubMed ID: 29290261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Diagnostic Programmed Cell Death 1-Ligand 1 Immunohistochemistry Assay for Nivolumab Therapy in Melanoma.
    Phillips T; Millett MM; Zhang X; Jansson M; Cleveland R; Simmons P; Cherryholmes G; Carnahan J; William J; Spaulding B; Satnick IR; Inzunza HD; Taylor C; Cogswell J; Novotny J; Oroudjev E; Winther H
    Appl Immunohistochem Mol Morphol; 2018 Jan; 26(1):6-12. PubMed ID: 29189265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study by using bronchofiberscope on radiotherapy of lung cancer--with special reference to squamous cell carcinoma at the hilar region].
    Ohbayashi K; Takada Y
    Nihon Gan Chiryo Gakkai Shi; 1983 Feb; 18(1):69-81. PubMed ID: 6864048
    [No Abstract]   [Full Text] [Related]  

  • 15. Afatinib treatment of a squamous lung cancer after tumor progression of nivolumab.
    Jin Y; Jiang Q; Xin T
    Thorac Cancer; 2018 Jan; 9(1):164-166. PubMed ID: 29027754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
    Brahmer J; Reckamp KL; Baas P; Crinò L; Eberhardt WE; Poddubskaya E; Antonia S; Pluzanski A; Vokes EE; Holgado E; Waterhouse D; Ready N; Gainor J; Arén Frontera O; Havel L; Steins M; Garassino MC; Aerts JG; Domine M; Paz-Ares L; Reck M; Baudelet C; Harbison CT; Lestini B; Spigel DR
    N Engl J Med; 2015 Jul; 373(2):123-35. PubMed ID: 26028407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autopsy findings in lung cancer treated with megavoltage radiotherapy.
    Rissanen PM; Tikka U; Holsti LR
    Acta Radiol Ther Phys Biol; 1968 Dec; 7(6):433-42. PubMed ID: 4980995
    [No Abstract]   [Full Text] [Related]  

  • 18. Nivolumab in squamous cell carcinoma of the head and neck.
    Specenier P
    Expert Rev Anticancer Ther; 2018 May; 18(5):409-420. PubMed ID: 29560755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-course radiation therapy in carcinoma of the lung.
    Abramson N; Cavanaugh PJ
    Radiology; 1970 Sep; 96(3):627-30. PubMed ID: 5456318
    [No Abstract]   [Full Text] [Related]  

  • 20. [Organ specificity of carcinoma originating from stratified epithelium and its treatment. 3. Pathological study of cancer under radiotherapy, with special reference to squamous cell carcinoma of the lung and esophagus].
    Shimosato Y
    Gan No Rinsho; 1969 Mar; 15(3):261-5. PubMed ID: 5816293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.